Ova donors demand compensation from government
By Asia News,
AsiaNews.it
| 02. 07. 2006
Seoul (AsiaNews) _ A coalition of 35 women_s groups filed a suit for compensation against the South Korean government on behalf of women suffering from side-effects after making uninformed ova donations to Prof Hwang Woo-suk for his research on stem cell embryos.
The women_s groups in association with Lawyers for a Democratic Society (Minbyun) claim that the donors who provided the _research material_ to the now disgraced researcher received no information on the side effects of excessive ova collection.
During the investigation into the fraudulent study, it was found that Hwang_s team used 2,221 ova, about fivefold the number Hwang had previously claimed, and that about 20 per cent of the donors have suffered side-effects from this invasive practice.
_Fifteen women donated eggs more than twice. The Mizmedi Hospital team even collected ova twice from a woman, who was hospitalized for side-effects after each donation,__ the women_s groups said in a statement. _It is an example of how the embryonic stem cell research, which received full national support, trampled on women_s human rights,_ the press release also said.
The groups...
Related Articles
By Rob Stein, NPR | 09.30.2025
Scientists have created human eggs containing genes from adult skin cells, a step that someday could help women who are infertile or gay couples have babies with their own genes but would also raise difficult ethical, social and legal issues...
By Aleks Krotoski, The Guardian | 09.28.2025
Imagine you’re the leader of one of the most powerful nations in the world. You have everything you could want at your disposal: power, influence, money. But, the problem is, your time at the top is fleeting. I’m not...
By Gregory Laub and Hannah Glaser, MedPage Today | 08.07.2025
In this MedPage Today interview, Leigh Turner, PhD, a professor of health policy and bioethics at the University of California Irvine, unpacks the growing influence of stem cell clinics and the blurred line between medicine and marketing. He explains how...
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...